Gene targeting by homologous recombination in embryonic stem (ES) cells is a powerful technique that allows any chosen gene to be genetically modified in a predetermined way 1 . In the past 20 years, thousands of genes have been modified in mouse ES cells by homo logous recombination with genetargeting vectors, yielding valu able research models. However, this ES cell-based genetargeting technique was previously only available for the mouse because of the inability to establish authentic ES cells from other species. Recently, we developed a new culture system that can support the efficient derivation and maintenance of germlinecompetent ES cells not only from mice but also, most importantly, from different strains of rats [2] [3] [4] . This culture system uses a serumfree N2B27 medium supplemented with three smallmolecule inhibitors (3i): CHIR99021, PD184352 and SU5402. CHIR99021 specifi cally inhibits glycogen synthase kinase 3, whereas PD184352 and SU5402 inhibit mitogenactivated protein kinase and fibroblast growth factor receptor tyrosine kinase, respectively 2 . Subsequently, we found that a more potent mitogenactivated protein kinase inhibitor, PD0325901, can be used to replace both PD184352 and SU5402 (ref. 2). Because the twoinhibitor (CHIR99021 and PD0325901), 2i medium is more effective than 3i medium for deriving and propagating rat ES cells, this protocol describes the use of 2i.
IntroDuctIon
Gene targeting by homologous recombination in embryonic stem (ES) cells is a powerful technique that allows any chosen gene to be genetically modified in a predetermined way 1 . In the past 20 years, thousands of genes have been modified in mouse ES cells by homo logous recombination with genetargeting vectors, yielding valu able research models. However, this ES cell-based genetargeting technique was previously only available for the mouse because of the inability to establish authentic ES cells from other species. Recently, we developed a new culture system that can support the efficient derivation and maintenance of germlinecompetent ES cells not only from mice but also, most importantly, from different strains of rats [2] [3] [4] . This culture system uses a serumfree N2B27 medium supplemented with three smallmolecule inhibitors (3i): CHIR99021, PD184352 and SU5402. CHIR99021 specifi cally inhibits glycogen synthase kinase 3, whereas PD184352 and SU5402 inhibit mitogenactivated protein kinase and fibroblast growth factor receptor tyrosine kinase, respectively 2 . Subsequently, we found that a more potent mitogenactivated protein kinase inhibitor, PD0325901, can be used to replace both PD184352 and SU5402 (ref. 2) . Because the twoinhibitor (CHIR99021 and PD0325901), 2i medium is more effective than 3i medium for deriving and propagating rat ES cells, this protocol describes the use of 2i.
Using the 2i or 3i medium, we and others have established ES cell lines at high efficiency from different strains of rats: dark agouti (DA), Fischer 344 (F344), SpragueDawley, Brown Norway, Wistar, LongEvans and spontaneously hypertensive rats (SHR; refs. 3-9 and unpublished data; Table 1 ). The availability of robust and germlinecompetent rat ES cells has opened the door for the application of ES cell-based gene targeting and related genome engineering technologies in rats. The potential utility of this tech nology was indicated in our recent report on the generation of Tp53 (also known as p53) gene knockout rats by homologous recombi nation in DA rat ES cells 10 . Efficient gene targeting by homologous recombination has also been reported in F344 and SpragueDawley rat ES cells 11 . These results have established a strong foundation for the development of genetargeted rat models and the pursuit of rat functional genomics. The rat offers a complementary model choice to the mouse because rat models have been shown to more closely mimic human disease than mouse models in several areas, including neurodegenerative disease 12 , nephropathy 13 , breast can cer 14 and rheumatoid arthritis 15 . Rats are approximately ten times larger than mice, allowing investigators to perform procedures such as nerve recordings, collection of tissue from small structures and serial blood sampling more easily.
Over the years, several technologies have been developed to modify the rat genome. These technologies include pronuclear microinjection 16 , lentiviral transgenesis 17 , NethylNnitrosourea mutagenesis 18, 19 , transposon mutagenesis [20] [21] [22] and zincfinger nuclease-mediated gene targeting [23] [24] [25] [26] [27] . The advantages and disad vantages of each technology are listed in Table 2 , and investiga tors should decide which technology is most appropriate for their applications. Currently, ES cell-based gene targeting is still the most effective technology to generate rats (or mice) with genes modified by homologous recombination and to restrict the genetic modifica tions to a desired group of tissues or to a chosen period during the development of the animal.
In this protocol, we describe how to generate gene knockout rats by homologous recombination in ES cells. The flowchart in Figure 1 shows the different stages of the process, which requires basic techniques in cell culture, molecular biology, rat embryology and rat surgery. Some procedures, such as karyotyping, vasectomy, embryo isolation and manipulation, microinjection and the trans fer of embryos to a pseudopregnant recipient, are provided as a service by animal and transgenic core facilities in many univer sities and research institutes. Genetargeting strategies involving homologous recombination have been used routinely to introduce various gene modifications into mice. However, rats are the species of choice in many areas of biomedical research, and we believe that researchers in many laboratories around the world will take advan tage of the wellestablished ES cell-based genetargeting technology to produce new rat models.
derivation of ES cells from other strains of rats [5] [6] [7] [8] [9] (Table 1) . Evidence indicates that ES cells can be established from most, if not all, strains of rats by using the 2i condition. The derivation procedure is rela tively simple. After the removal of the zona pellucida with Tyrode's solution, blastocysts are transferred to a fourwell plate precoated with feeders and cultured in 2i medium. ES cell lines can be estab lished from ~50% of the rat blastocysts that had been plated. Rat ES cell derivation efficiency can be increased if the inner cell mass is isolated by immunosurgery after the removal of the zona pellucida (M. Buehr, personal communication) . If a particular rat strain is characterized by low efficiency in deriving ES cells, isolation of the inner cell mass will most likely increase the chance of success. Feeders are essential for the maintenance of pluripotent rat ES cells in the 2i condition. Fibroblasts derived from either mouse or rat embryos can be used for rat ES cell culture. Before use as feeders, embryonic fibroblasts must be mitotically inactivated either by γirradiation or by mitomycin C treatment 28 . Rat ES cells grow as loosely attached or floating aggregates in the 2i condition; hence, extra care must be taken to avoid washing away the cells when changing the medium or passaging the cells. For routine passaging, we detach rat ES cells by pipetting and collect them by centrifugation, after which trypsin is added to dissociate the cell aggregates into single cells. Passaging cells in this way can also avoid the carryover of feeders, which adversely affects rat ES cell growth.
Design of the targeting vector.
Gene targeting by homologous recombination in ES cells has provided a powerful means to elu cidate gene function and create gene knockout animal models 1 . 
The design of the genetargeting vector is the first critical step 29 . Key components of a targeting vector include two homology arms with the same DNA sequences as the genomic DNA fragments flanking the region to be modified, and both a positive and a negative selection marker. Construction of the targeting vectors has been described in detail in various protocols [28] [29] [30] [31] [32] . Although the basic principle for designing a genetargeting vector is the same for both the mouse and the rat, construction of a gene targeting vector for the rat requires several modifications to the classic strategy. The first of these is the choice of promoter used to drive the expression of the positive selection marker. In mouse genetargeting vectors, phosphoglycerate kinase (PGK) promoter is most often used to control the selection marker gene expression. Rat ES cells are very sensitive to drug selection, and the activity of the PGK promoter is too weak for the efficient isolation of drugresistant colonies of rat ES cells. The cytomegalovirus early enhancer/chicken βactin (CAG) promoter has a much stronger activity than that of the PGK promoter. The use of the CAG pro moter to drive the expression of the positive selection marker has been proven to be very effective for isolating drugresistant colonies in rat ES cells 10 . The second modification to the strategy is the choice of the nega tive selection marker, which is the gene used to eliminate cells with table 2 | Advantages and disadvantages of different methods for generating transgenic rats.
Method advantages Disadvantages
Pronuclear injection 16 The most straightforward method to generate transgenic rats in the absence of rat ES cells The third modification to the strategy involves the source of homology arms. Currently, there is no information available for DA rat bacterial artificial chromosome end sequence. Homology arms can be amplified from DA rat genomic DNA by using PCR based methods with highfidelity DNA polymerases, such as the Expand High Fidelity PLUS PCR System (Roche) or Phusion DNA polymerase (New England Biolabs). The published rat genomic sequences are from the Brown Norway strain of rats 33 . If there are any sequence differences between the amplified DNA and the published data, it is important to determine whether these Introduction of targeting vectors into rat ES cells. Several methods are available for introducing foreign DNA into ES cells, including electroporation, nucleofection and chemicalbased transfection. We have evaluated these methods, and our results suggest that electroporation is still the most effective means of generating correctly genetargeted rat ES cell clones (unpublished data). The variable quality of mouse ES cell lines often hinders the development of the mouse model containing a modified gene locus 34 . This likely applies to the rat as well. The major factors that affect the quality of ES cells and their ability to generate germline chimeras include culture medium, quality of feeder cells, methods of passaging and the number of passages 28 . Under suboptimal culture conditions, ES cells progressively acquire chromosomal abnormalities as they are passaged, and this is one of the major reasons as to why ES cells might fail to contribute to the germ line. The quality of rat ES cells should be regularly monitored by examining their karyotypes, in vitro differentiation potential and expression of pluripotency markers, and also by determining how efficiently they produce germline chimeras, which still remains the goldstandard test 3, 4, 28 . Rat ES cells grow as compact dome shaped colonies in the 2i condition, and as the number of pas sages increases, some rat ES cells start attaching to the feeders and forming flat colonies. Rat ES cells with flat colony morphology should not be used for gene targeting, because they are most likely karyotypically abnormal 10 .
Isolation of gene-targeted rat ES cell colonies. Rat ES cells cul tured in the 2i condition are very sensitive to drug selection. We administer the selection drug at half of the normal concentration used for mouse ES cells and apply a pulse selection scheme to increase the selection efficiency 10 . Our tests on ES cells derived from DA, F344 and SpragueDawley rats showed this pulseselection scheme to be highly effective when using puromycin, G418 or hygromycin. However, it is possible that this selection scheme will not work effectively for other drugs or a particular rat ES cell line. If this is the case, the investigators should optimize the selection condition by determining the killing curve of the selection drug on the rat ES cell line that they use. As mentioned above, most of the rat ES cell colonies are either floating or loosely attached to the feeders, and extra care should be taken when changing the medium so that these colonies are not washed away. After drug selection is completed, colonies can be picked using the simple, efficient method depicted in up to 500 colonies can be picked, dissociated and seeded in < 3 h. The dissociated colonies are transferred into duplicate 96well plates, using a multichannel pipette.
Freezing and thawing of the rat ES cells cultured in the 96well plate results in a poor recovery rate. To circumvent this problem, we split each rat ES cell colony into two 96well plates, with one plate having three times more cells than the other. The plate with more cells is used for the initial screening by PCR, which takes 1-2 d to complete, whereas cells in the other plate are maintained in culture. Colonies that test positive in PCR screening are then expanded from the duplicate plate for confirmation by Southern blot, sequencing analysis or both. The strategies for confirmation of the targeting events in rat ES cells by Southern blot are essentially the same as in mouse ES cells 28, 35 . The design of PCR primers and optimization of PCR conditions are critical for the initial screening. One of the PCR primer pair should be located on the genomic DNA beyond the 3′ short arm and the other located on the drugresistance cas sette (Fig. 4) . If mouse embryonic fibroblasts (MEFs) are used as feeder layers, BLAST the PCR screening primer sequences against mouse genomic DNA sequences to rule out potential nonspecific amplifications. We recommend constructing a control vector con taining the 3′ short homology arm with a 300bp to 500bp exten sion in which one of the PCR primer pair is located (Fig. 4) . Rat ES cells transfected with the control plasmid mimic the targeting event and can therefore be used to optimize the PCR screening con ditions. The genomic DNA extracted from these rat ES cells is also run in parallel with PCR primers as a positive control for the PCR screening.
Strain combination. Different strains of rats have different suitabilities as models for particular human diseases. For instance, the LongEvans rat is a good model for dietinduced obesity, and the spontaneous hypertensive rat has been widely used for the study of hypertension. The availabil ity of ES cells from different strains of rats provides investigators the option of pro ducing genetargeted rat models based on a relevant genetic background. However, for the production of genetargeted rats by ES cellbased technologies, it is essential that rat ES cells are able to contribute to the formation of chimeras and reenter the germline. Therefore, before performing genetargeting experiments on a rat ES cell line, the investigator must determine whether the line is germlinecompetent and identify the ideal strain combination that leads to its efficient germline transmission.
In the production of ES cellmouse chi meras, it has been shown that the genetic background of the host embryos is one factor that determines the efficiency with which the ES cell genome is transmitted to the progeny. One of the early findings during the development of gene targeting in 129 mouse ES cells was that the proportion of chimeras that resulted in germline transmission was determined by the genetic background of the host blastocyst. Schwartzberg et al. 36 used out bred MF1, outbred CD1 and inbred C57BL/6 mouse blastocysts to produce chimeras with CCE 129 mouse ES cells. All three blastocyst donor mouse strains produced ES cellmouse chimeras. However, only C57BL/6 host blastocysts produced chimeras that transmitted the genetically modified ES cell genome through the germline. The same result has been observed for the mouse C57BL/6 ES cell lines. The efficiency of germline transmission is increased when the host blastocyst that is used to make ES cell chimeras with C57BL/6 ES cells is derived from C57BL/6Tyrc2J/J mice instead of BALB/c, SWR, FVB/N, C57BL/6Tyrcbrd or 129/Sv mice [37] [38] [39] [40] [41] . The strain combination is another controlling factor in the germ line transmission of rat ES cells. Our results suggest that DA rat ES cells can transmit through the germline when they are injected into F344 rat blastocysts, but not when they are injected into Sprague Dawley rat blastocysts 4 . ES cells derived from SpragueDawley and Wistar rats have also been shown to be germlinecompetent 3, 5, 8 . Another factor to be considered when choosing the strain com bination is the coat color genetic background. The identifica tion of chimerism and germline transmission can be facilitated by combining rat strains that have distinct coat colors (Fig. 5) . 
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Targeted locus
Positive control vector Identification of the ideal strain combination will facilitate the broad application of ES cell-based technology for the production of genetargeted rat models. In this protocol, we describe gene targeting performed in DA rat ES cells. We have deposited sev eral germlinecompetent DA rat ES cell lines at the Rat Resource and Research Center in Columbia, Missouri, USA (http://www. rrrc.us/), which has begun distributing the rat ES cell lines to the research community. 
Box 1 | CoNSTRUCTIoN oF RAT GENE-TARGETING VECToRS • tIMInG 30 D
1. Extract genomic DNA from isogenic rat tissues or rat ES cells. 2. Set up and run two separate PCR reactions to amplify the 5′ and 3′ homology arms using the Expand High Fidelity PCR System. 3. Set up and run two separate PCR reactions to amplify pUC (one for cloning the 5′ homology arm and one for cloning the 3′ homology arm). 4. Separate the PCR products for the two homology arms (from Step 2) and the modified pUC cloning vectors (from Step 3) by electrophoresis on 1% (wt/vol) agarose gels. Purify the PCR products from the gel, using the QIAquick Gel Extraction Kit. 5. Set up two separate infusion cloning reactions between each of the two homology arms and the relevant modified pUC cloning vector, according to the manufacturer's instructions. Digestion reaction with a restriction enzyme is not required in this step. 6. Prepare mini-preps of the recombinant pUC vectors containing the homology arm and confirm the sequence of the homology arms by DNA sequencing. 7. Digest the relevant plasmid for one homology arm with appropriate restriction enzymes and subclone the homology arm into the targeting vector backbone plasmid containing a CAG-driven positive selection cassette. 8. Prepare mini-preps of the modified targeting vector containing one homology arm. Repeat Step 7 to insert the other homology arm and the PGK-DTA negative selection cassette into the backbone plasmid (Fig. 2) . intraperitoneally. We use Sprague-Dawley males. 2. After anesthesia, sanitize the shaved lower abdomen by swabbing with 70% (vol/vol) alcohol. Make a vertical incision on the testis membrane close to the left side of the midline wall. 3. Carefully push the testis to the left, using blunt forceps, and isolate the vas deferens from the surrounding tissue and cut off a part in the loop. 4. Clean the wound and suture the skin with stitches. 5. Repeat steps 3 and 4 on the other testis. 6. Keep the rat warm until it has fully recovered from the anesthesia. Place the rat back into a clean cage and house it as described in EQUIPMENT SETUP. 7. At 3-4 weeks after surgery, set up matings between the vasectomized male and two females to confirm the success of the vasectomy. We use Sprague-Dawley females. Pregnancy is normally apparent within 2 weeks; if pregnancy is not visible after this time, the male can be used for inducing pseudo-pregnant females. preparing pseudo-pregnant females 1. Set up matings between female Sprague-Dawley rats and vasectomized Sprague-Dawley males 4 d before the planned injection date. 2. Check for mating by the presence of copulation plugs the following morning. 3. Cage the plugged females individually for uterine transfer on the injection date.
REAGENT SETUP b-mercaptoethanol Prepare 0.1 M stock solution by diluting 100µl βmercaptoethanol with 14.1 ml of distilled H 2 O. Sterilize through a 0.2µm filter and store at 4 °C for up to 1 month. ! cautIon It is flammable; harmful if swallowed; toxic when in contact with skin and eye; and use protective gloves and safety glasses when handling. Gelatin 10× stock solution Dissolve 5 g in 500 ml of distilled H 2 O to produce 1% (wt/vol) gelatin stock. Autoclave and store in 50ml aliquots at 4 °C for up to 3 months. Gelatin 1× solution Add 50 ml of prewarmed 1% (wt/vol) gelatin to 450 ml of PBS. Store at 4 °C for up to 1 month. Insulin Dissolve in sterile 0.01 M HCl overnight at 4 °C to produce a 10 mg ml − 1 stock solution. Store in 1ml aliquots at − 20 °C.  crItIcal Insulin does not dis solve readily; hence, ensure that the suspension is mixed well before aliquotting. Apo-transferrin Dissolve in sterile distilled H 2 O to produce a 100 mg ml − 1 stock solution. Store in 1ml aliquots at − 20 °C. Progesterone Dissolve 3 mg in 5ml ethanol to produce a 0.6 mg ml − 1 stock solution. Sterilize through a 0.2µm filter. Store in 0.5ml aliquots at − 20 °C. It is good for at least 5 years. Freezing and thawing is fine. Putrescine Dissolve 1.6 g in 10ml distilled H 2 O to produce a 160 mg ml − 1 stock. Sterilize through a 0.2µm filter. Store in 1ml aliquots at − 20 °C. It is good for at least 5 years. Freezing and thawing is fine. Sodium selenite Dissolve 2.59 mg in 5ml distilled H 2 O to produce a 3 mM stock. Sterilize through a 0.2µm filter. Store in 0.5ml aliquots at − 20 °C. It is good for at least 5 years. Freezing and thawing is fine. CHIR99021 Dissolve 4 mg of CHIR99021 in 860µl DMSO to produce a 10 mM stock. Store in 100µl aliquots at − 20 °C. It can be stored for at least 3 years. PD0325901 Dissolve 4 mg of PD0325901 in 830µl DMSO to produce a 10 mM stock. Store in 50µl aliquots at − 20 °C. It can be stored for at least 3 years. N2 100× stock (10 ml) To 7.187ml DMEM/F12 medium, add 0.67 ml of 75 mg ml − 1 BSA, 33 µl of 0.6 mg ml − 1 progesterone solution, 100 µl of 160 mg ml − 1 putrescine solution, 10 µl of 3 mM sodium selenite solution, 1 ml of 100 mg ml − 1 apotransferrin and 1 ml of 10 mg ml − 1 insulin. Mix well by pipetting and store in 1 ml aliquots at − 20 °C. It can be stored for up to 6 months. DMEM/F12-N2 medium To 100 ml of DMEM/F12, add 1 ml of N2 100× stock solution. The final concentration of each component of N2 in the DMEM/F12N2 medium is as follows: insulin 10 µg ml . Neurobasal/B27 medium To 100 ml of neurobasal medium, add 2 ml of B27 and 0.5 ml of 200 mM lglutamine. N2B27 medium Mix DMEM/F12N2 medium with neurobasal/B27 medium at a ratio of 1:1. To 200 ml of N2B27 medium, add 200 µl of 0.1 M βmercaptoethanol. The final concentration of βmercaptoethanol in N2B27 medium is 0.1 mM. Store at 4 °C for up to 1 month. 2i medium To 100 ml of N2B27 medium, add 30 µl of 10 mM CHIR99021 and 10 µl of 10 mM PD0325901. The final concentrations of CHIR99021 and PD0325901 in the 2i medium are 3 and 1 µM, respectively. Store at 4 °C for up to 1 month. Trypsin-EDTA solution (0.025% (wt/vol)) Add 5 ml of 2.5% (wt/vol) trypsin, 5 ml of chicken serum and 0.5 ml of 0.5 M EDTA to 500 ml of sterile PBS. Mix well and store in 30 ml aliquots at − 20 °C. It can be stored for up to 6 months. MEF medium Add 50 ml of heatinactivated fetal bovine serum, 5 ml of 200 mM Lglutamine solution and 5 ml of penicillinstreptomycin solution to 500 ml of GMEM medium. Store at 4 °C for up to 1 month. MEF feeders We use standard methods to prepare MEF feeders 28 . Mitoti cally inactivate MEFs either by γirradiation or mitomycinC treatment. Plate mitotically inactivated MEFs into gelatincoated dishes at a density of 2 × 10 4 to 3 × 10 4 cells per cm 2 and culture in MEF medium. Prepare MEF feedercoated plates in advance and use within 1 week. MEFs derived from the CF1 mouse strain are used for routine rat ES cell culture. MEFs prepared from other strains of mice should also work for rat ES cell culture. When rat ES cells are under drug selection, they are cultured on drugresistant MEFs, such as DR4 MEFs, which are resistant to G418, hygromycin, puromycin and 6thioguanine 10 . Freezing medium Dissolve 10% (vol/vol) DMSO in MEF medium. Prepare just before use. Primer design for amplifying homology arms Access the University of California Santa Cruz (UCSC) genome browser website and find the genomic DNA sequence of the gene of interest for performing gene targeting. Retrieve the whole gene sequence and ~15 kb of upstream and ~15 kb of downstream sequences. Import the DNA sequence into sequence analysis software, such as Clone Manager (Scientific & Educational Software). Decide on the location and size of short and long homology arms based on the structure and function of the gene, information of exons and introns, percentages of repetitive sequence and the restriction enzyme sites. The minimal length of the homology arms required for successful gene targeting in rat ES cells has not been determined yet. From our experience, ~6 kb of the long homology arm and ~1.5 kb of the short homology arm are sufficient for gene targeting by homologous recombination in rat ES cells. Design a PCR primer pair to individually amplify the 5′ and 3′ homology arms from genomic DNA extracted from isogenic rat tissues or rat ES cells. The minimum require ments for the PCR primers are described as follows: length, 23-30 bp; annealing temperature, 60-68 °C; and G + C content, 40-60%. Primer design for amplifying pUC vector Each primer in this pair contains a 15bp sequence complementary to the 5′ end of the primer used for amplifying either the 5′ or the 3′ homology arm from genomic DNA. A restriction enzyme site is also introduced into each primer to facilitate the subcloning of the homology arm into the targeting vector backbone plasmid (Box 1 and Fig. 2) . Primer design for PCR screening Design a PCR primer pair for the initial screening of correctly targeted rat ES cells. As shown in Figure 4 , one of the PCR primer pair should be located on the genomic DNA beyond the 3′ short arm and the other located on the drug resistance cassette. The minimum requirements for the PCR primers are described as follows: length, 20-25 bp; annealing temperature, 58-65 °C; and G + C content, 40-60%. EQUIPMENT SETUP Animal housing Mice and rats are housed in the vivarium and maintained under routine husbandry practices, according to the guidelines approved by the Institutional Animal Care and Use Committee. Rats undergoing surgical procedures are housed solitarily for the first 1-2 weeks after surgery. Rat pups are weaned at the age of 4-5 weeks. .c.) . Kill the pregnant rat at 4.5 d.p.c by CO 2 asphyxiation, followed by thoracotomy. Timed-pregnant rats can also be ordered from Harlan Laboratories or Charles River Laboratories International. We use DA rats for preparing ES cells. ! cautIon Animal experiments should be performed according to the investigator's protocols approved by international and institutional regulations.
2| Perform surgery to isolate the uterus and flush out the blastocysts using N2B27 medium. The procedures are the same as those described in the mouse 28, 42 . First, lay the rat on its back and cleanse the abdominal skin and fur with 70% (vol/vol) alcohol. Expose the uterus by making an incision along the midsection with scissors. Cut out the uterus and transfer it to a 6-cm dish prefilled with 3 ml of PBS. Remove the mesometrium of the uterus with fine scissors. Finally, flush the blastocysts from the uterus with a 27-gauge needle using N2B27 medium.
3|
Collect blastocysts using an embryo-handling pipette and wash them using two drops of acidic Tyrode's solution.
4|
Transfer blastocysts to a fresh drop of acidic Tyrode's solution and monitor them under a microscope; when the zona pellucida has dissolved, immediately wash blastocysts with two drops of fresh N2B27 medium.
5|
Replace the MEF medium with 500 µl of 2i medium in each well of the four-well plate preseeded with MEF feeders. MEF feeders need to be prepared in advance (see REAGENT SETUP). Transfer up to six blastocysts to each well, and culture at 37 °C with 5% CO 2 for 4-5 d. It is not necessary to change the medium during this period.
6|
Detach and transfer the outgrowth of each blastocyst into a 1.5-ml Eppendorf tube containing 200 µl of 0.025% (wt/vol) trypsin-EDTA solution, using a mouth-controlled glass pipette. Incubate at 37 °C for 3 min.  crItIcal step Use a glass pipette, the diameter of which at the tip is just a little bigger than the outgrowth. Each outgrowth should be handled separately.
7| Add 1 ml of MEF medium to the tube and gently pipette up and down four to six times to break up the outgrowth.
8|
Centrifuge at 200g for 3 min. Aspirate the supernatant and resuspend the pellet in 500 µl of N2B27 medium. Centrifuge again at 200g for 3 min and aspirate the supernatant. Resuspend the pellet in 500 µl of 2i medium and transfer the cells to a new four-well plate preseeded with MEF feeders (see REAGENT SETUP).  crItIcal step Rat ES cells maintained in serum-free 2i medium are very sensitive to even a small amount of residual serum or trypsin. Take extra care to remove any residual serum and trypsin, especially when using the conventional method to disaggregate the outgrowth 42 .
9| Incubate at 37 °C in a humidified 5% CO 2 incubator. Add 250 µl of fresh 2i medium to each well on day 2. ES cell colonies emerge after 3-5 d of incubation. It is not necessary to change the medium during this period.
? troublesHootInG 10| Approximately 3-5 d after the first disaggregation, check each well of the four-well plate under a microscope for the appearance of ES cell colonies.
11| Detach ES cell colonies by pipetting up and down several times with a 1-ml pipette tip; the contents of each well should be handled separately. Rat ES cell colonies cultured in the 2i medium attach loosely to the feeders and are easily detached by pipetting.
12|
Transfer the colonies to a 1.5-ml Eppendorf tube and centrifuge at 200g for 3 min. Carefully aspirate off the supernatant and resuspend the pellet in 200 µl of 0.025% (wt/vol) trypsin-EDTA solution. Incubate at 37 °C for 3 min.
13| Add 1 ml of MEF medium to the tube and pipette up and down four to six times with a 1-ml pipette tip to dissociate the colonies into single cells. Centrifuge at 200g for 3 min and carefully aspirate off the supernatant.
14|
Dissociate the cell pellet with 500 µl of 2i medium and transfer the cells to a new four-well plate preseeded with MEF feeders (see REAGENT SETUP). Incubate at 37 °C in a humidified 5% CO 2 incubator for 2-3 d (passage 1).
15| Passage the cells every 2-3 d, as described in Steps 11-14. Gradually increase the size of the well, according to the number of cells that are present. It is not necessary to change the medium during the 2-to 3-d period between passaging. However, if the medium turns yellow, add some fresh 2i medium to the well. For example, if there is 1 ml of 2i medium in the well, add 0.5 ml of fresh 2i medium. When the total cell number of an individual rat ES cell clone is more than 0.5 million, the cells can be passaged or frozen, as described in box 3, or used directly in Step 16.
Introduction of targeting vector into rat es cells by electroporation • tIMInG 4 h 16|
Grow and collect the rat ES cells as described in Steps 11-15 and in box 3. A total of 0.5-1 × 10 7 rat ES cells are usually required for each transfection.  crItIcal step Use the rat ES cells that have previously been proven to be germline competent.
17|
Wash the rat ES cells twice with 10 ml of PBS. Collect the cells by centrifugation at 200g for 3 min. Resuspend the cell pellet in 0.7 ml of PBS.
18|
Dissolve 50-100 µg of linearized gene-targeting vector (from step 9 in box 1) in 0.1 ml of PBS. Add the linearized plasmid DNA to the cell suspension and mix by gently inverting the tube.
19|
Transfer DNA/rat ES cell mixture to a Gene Pulser cuvette (4-mm gap). Perform electroporation at a pulse voltage of 200 V, 500 µF on Bio-Rad Gene Pulser XCell.
20|
Transfer the electroporated rat ES cells to three 10-cm tissue culture dishes preseeded with MEFs (see REAGENT SETUP) and culture in 2i medium at 37 °C in a humidified 5% CO 2 incubator.  crItIcal step The MEFs should be resistant to the drug used to select transfected rat ES cells. We use DR4 MEFs for the culture of rat ES cells that are under selection with puromycin, G418 or hygromycin. ? troublesHootInG selection of drug-resistant colonies • tIMInG 9 d 21| One day after electroporation, replace the medium with fresh 2i medium supplemented with the appropriate selection drug (e.g., 0.5 µg ml − 1 of puromycin).  crItIcal step Rat ES cells loosely attach to feeders or grow as floating colonies; hence, do not aspirate off the medium directly from the culture dish. Instead, transfer the medium from the 10-cm culture dish to a sterile 15-ml conical tube and immediately add fresh 2i medium with the selection drug back into the culture dish. Collect rat ES cells in the culture medium by centrifugation and add them back into the culture.
22|
After incubation in the presence of selection drug for 2 d, replace the medium with fresh 2i medium and culture the cells in the absence of selection drug for 1 d. This represents one selection cycle. Repeat this selection cycle two more times.  crItIcal step Rat ES cells are very sensitive to drug selection. Do not add the drug continuously, as doing so will kill rat ES cells even if they are transfected. It is important to determine the killing curve of each drug for the rat ES cell line used for gene transfection. This will help to optimize the concentration for drug selection. ? troublesHootInG picking drug-resistant colonies • tIMInG 4 h 23| Gently detach rat ES cell colonies from feeders by pipetting. Transfer the medium containing ES colonies into a sterile 15-ml conical tube.
24| Spin down to pool the colonies at 100g for 3 min. Aspirate off the supernatant and resuspend the colonies in 1 ml of 2i medium. Transfer the colonies to a center-well organ-culture dish or a 6-cm Petri dish.
25|
Dispense drops of 0.025% (wt/vol) trypsin-EDTA solution (10 µl per drop) to a 150-mm Petri dish using a 10-to 100-µl multichannel pipette.
26|
Transfer the rat ES colonies into drops of trypsin/EDTA solution (one colony per drop), using a mouth-controlled glass pipette, as illustrated in Figure 3 . Incubate at room temperature (25 °C) for 3 min.
27|
Transfer the trypsin/EDTA-treated ES colonies into a 96-well plate precoated with MEF feeders (see REAGENT SETUP). Each well contains 200 µl of 2i medium supplemented with 1% (vol/vol) FBS. Addition of FBS to the 2i medium is necessary to neutralize the trypsin.
28|
Pipette up and down several times to dissociate the rat ES cell colonies into single cells. Transfer 50 µl of the cell suspension from each well into a duplicate 96-well plate preseeded with MEF feeders. Add another 50 µl of fresh 2i medium to each well. Culture at 37 °C in a humidified 5% CO 2 incubator.  crItIcal step This duplicate plate with fewer cells is used to retrieve positive clones at Step 35 after PCR screening (Steps 31-34).
29|
Repeat Steps 23-28 until a sufficient number of colonies is processed. The next morning, carefully aspirate off the medium and add 100 µl of fresh 2i medium to each well, using a multichannel pipette.  crItIcal step Rat ES cells are very sensitive to serum and trypsin; hence, it is critical to replace the serum and trypsin-containing medium with fresh 2i medium within 24 h of plating.
30|
Add 50-100 µl of fresh 2i medium to each well every 2-3 d. After 6-8 d of plating, ES cell colonies will usually appear in most of the wells. screening clones by pcr • tIMInG 2 d 31| Aspirate off the medium from each well of the 96-well plate used for PCR screening (Step 30). Add 100 µl of the genomic lysis buffer (provided in the ZR-96 Quick-gDNA kit) to each well and extract genomic DNA from each rat ES cell clone, according to the manufacturer's instructions; elute DNA in 30 µl of distilled water.
32|
Set up a PCR mix as tabulated below.  crItIcal step The optimum PCR screening conditions likely vary among different gene-targeting vectors; therefore, it is important to optimize the PCR screening condition for each targeting vector before performing gene-targeting experiments. To optimize the PCR conditions, first construct a positive control vector as shown in Figure 4 . Next, generate and expand rat ES cells with the positive control vector integrated stably. Finally, use genomic DNA extracted from these rat ES cells to optimize the PCR conditions. This genomic DNA can also be run with PCR screening primers as a positive control. 36| Extract genomic DNA from each clone, e.g., using Puregene Tissue Core Kit A, according to the manufacturer's instructions.
37|
Digest genomic DNA samples with appropriate restriction enzymes and separate on 1% (wt/vol) agarose gels.
38| Denature, neutralize and blot the DNA on a membrane, using standard methods 35 .  crItIcal step Southern blot strategies for the verification of gene-targeting events in rat ES cells are essentially the same, as described in mouse ES cells 29, 43 . For the confirmation of accurate gene targeting, genomic DNA samples should be analyzed by Southern blot, using 5′, 3′ and internal probes.
39|
Synthesize the digoxigenin-labeled hybridization probes by PCR, e.g., using the Expand High Fidelity PCR System. Set up reactions as described in the table below. 40| Run the PCR, using the following conditions. 
45|
One day before microinjection, split the cells to ensure 50-70% confluence by the next day.
46|
On the day of injection, collect the cells as described in Steps 11-15 and box 3 and resuspend them in 0.5-1.0 ml of N2B27 medium.  crItIcal step Ensure that the cell aggregates are dissociated into single cells.
47|
Transfer the cell suspension into a sterile 1.5-ml Eppendorf tube and place it on ice while preparing for microinjection.
preparation of blastocysts • tIMInG 4 h 48| Collect blastocysts from timed-pregnant F344 rats at 4.5 d.p.c., as described in Steps 1-2.
49| Wash the blastocysts with several drops of M2 medium to rinse off the debris.
50|
Transfer the blastocysts to a culture dish containing a few drops of M16 medium.
51|
Incubate for 1-4 h at 37 °C in a humidified 5% CO 2 incubator to allow the expansion of the blastocyst cavity.
Microinjection of rat es cells
• tIMInG 2 h 52| Assemble the microinjection setup. We use a standard setup as previously described 28 .
53|
Pick up well-expanded blastocysts and immobilize them with a holding pipette.
54| Inject 12-15 ES cells into the blastocyst cavity.
55| Place the injected blastocysts back into the incubator until all blastocysts are injected and ready for transfer to pseudo-pregnant surrogate mothers. 58| Make an incision in the skin right above the ovary, as well as in the peritoneal wall over the left oviduct, using fine dissection scissors.
59|
Locate the fat pad attached to the ovary, pull it out and secure it with a Serrafine clamp to exteriorize the ovary, the oviduct and the upper part of the uterus.
60|
Hold the top of the uterus gently with blunt forceps. Using a 27-gauge needle, make a hole in the uterus a few millimeters down from the uterotubal junction.
61| Transfer 8-10 injected blastocysts (from Step 55) into the uterus, using the glass capillary, through the hole made by the needle.
62|
Place the uterus, oviduct and ovary back inside the body cavity. Sew up the muscle wall and the skin.
63|
At the end of the procedure, place the rat in a clean cage and maintain it warm until it recovers from anesthesia. Cage the rat by itself (see EQUIPMENT SETUP). The pups will be born 18-19 d after the transfer of blastocysts into the uterus of the surrogate female rat.  crItIcal step Maintain the rat warm during and after the surgery. Wait for the rat to fully recover from anesthesia before returning it to the vivarium. 67| Identify homozygote mutant rats by genotyping tail biopsies using standard methods 28 .
68| Confirm the homozygosity of the rats by northern blot and western blot analyses, using standard methods 35 .
? troublesHootInG Troubleshooting advice can be found in table 3. antIcIpateD results Rat ES cell lines can be established from ~50% of the rat blastocysts that are plated under 2i culture conditions. Similar to mouse ES cells, rat ES cells are routinely passaged using trypsin and can be frozen and thawed using conventional methods with typical recovery rates of over 90%. Rat ES cells grow as compact dome-shaped colonies (Fig. 7a) and express pluripotency markers ( Fig. 7b-e) . Gene-targeted rat ES cells can be routinely generated by homologous recombination. Gene-targeting efficiency in rat ES cells is similar to that in mouse ES cells. Rat ES cells are very sensitive to drug selection and they cannot survive if the selection drug is added continuously, even if they are transfected. To overcome this problem, we add selection drugs at half the concentration used for mouse ES cells and apply a 'pulsed' drug selection regimen, as described in the procedure. The majority of the colonies that emerge after applying the 'pulsed' drug selection regimen are transfected (Fig. 8) . On average, 300-500 drug-resistant colonies can be recovered from 7 × 10 6 rat ES cells after electroporation with targeting vectors. The targeted mutations in rat ES cells can transmit through the germline to produce gene-targeted animals 10 . The quality of rat ES cells is the major factor affecting their germline competency. Therefore, it is important to karyotype rat ES cells before microinjecting them into recipient blastocysts. The genetic background of the host embryo chosen for the production of ES cell-rat chimeras has a dramatic effect on the successful production of chimeric animals that transmit the ES cell haplotype. Germline transmission of the rat ES cell genome can be achieved when DA rat ES cells are injected into F344 rat blastocysts but not when injected into Sprague-Dawley rat blastocysts 4, 10 . The resultant male chimeric rats are crossed with Sprague-Dawley or F344 rats to verify the germline transmission of targeted DA rat ES cells. 
